rs1546737

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_015512.5(DNAH1):​c.6957C>T​(p.His2319His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.299 in 1,612,634 control chromosomes in the GnomAD database, including 75,624 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 5629 hom., cov: 33)
Exomes 𝑓: 0.30 ( 69995 hom. )

Consequence

DNAH1
NM_015512.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.509

Publications

33 publications found
Variant links:
Genes affected
DNAH1 (HGNC:2940): (dynein axonemal heavy chain 1) This gene encodes an inner dynein arm heavy chain that provides structural support between the radial spokes and the outer doublet of the sperm tail. Naturally occurring mutations in this gene are associated with primary ciliary dyskinesia and multiple morphological anomalies of the flagella that result in asthenozoospermia and male infertility. Mice with a homozygous knockout of the orthologous gene are viable but have reduced sperm motility and are infertile. [provided by RefSeq, Feb 2017]
DNAH1 Gene-Disease associations (from GenCC):
  • spermatogenic failure 18
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • ciliary dyskinesia, primary, 37
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic male infertility due to sperm motility disorder
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 3-52373025-C-T is Benign according to our data. Variant chr3-52373025-C-T is described in ClinVar as Benign. ClinVar VariationId is 402601.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.509 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.324 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH1NM_015512.5 linkc.6957C>T p.His2319His synonymous_variant Exon 44 of 78 ENST00000420323.7 NP_056327.4 Q9P2D7-4A0A140VJI6
DNAH1XM_017006129.2 linkc.7026C>T p.His2342His synonymous_variant Exon 46 of 80 XP_016861618.1
DNAH1XM_017006130.2 linkc.6957C>T p.His2319His synonymous_variant Exon 45 of 79 XP_016861619.1 Q9P2D7-4A0A140VJI6
DNAH1XM_017006131.2 linkc.7026C>T p.His2342His synonymous_variant Exon 46 of 79 XP_016861620.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH1ENST00000420323.7 linkc.6957C>T p.His2319His synonymous_variant Exon 44 of 78 1 NM_015512.5 ENSP00000401514.2 Q9P2D7-4
DNAH1ENST00000486752.5 linkn.7218C>T non_coding_transcript_exon_variant Exon 44 of 77 2

Frequencies

GnomAD3 genomes
AF:
0.243
AC:
36927
AN:
152112
Hom.:
5630
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0594
Gnomad AMI
AF:
0.330
Gnomad AMR
AF:
0.266
Gnomad ASJ
AF:
0.362
Gnomad EAS
AF:
0.184
Gnomad SAS
AF:
0.264
Gnomad FIN
AF:
0.352
Gnomad MID
AF:
0.323
Gnomad NFE
AF:
0.327
Gnomad OTH
AF:
0.255
GnomAD2 exomes
AF:
0.287
AC:
71059
AN:
247388
AF XY:
0.293
show subpopulations
Gnomad AFR exome
AF:
0.0516
Gnomad AMR exome
AF:
0.250
Gnomad ASJ exome
AF:
0.371
Gnomad EAS exome
AF:
0.167
Gnomad FIN exome
AF:
0.362
Gnomad NFE exome
AF:
0.335
Gnomad OTH exome
AF:
0.307
GnomAD4 exome
AF:
0.305
AC:
445084
AN:
1460404
Hom.:
69995
Cov.:
37
AF XY:
0.305
AC XY:
221469
AN XY:
726510
show subpopulations
African (AFR)
AF:
0.0447
AC:
1497
AN:
33466
American (AMR)
AF:
0.252
AC:
11247
AN:
44648
Ashkenazi Jewish (ASJ)
AF:
0.371
AC:
9688
AN:
26124
East Asian (EAS)
AF:
0.259
AC:
10263
AN:
39682
South Asian (SAS)
AF:
0.256
AC:
22083
AN:
86228
European-Finnish (FIN)
AF:
0.360
AC:
18914
AN:
52594
Middle Eastern (MID)
AF:
0.318
AC:
1831
AN:
5762
European-Non Finnish (NFE)
AF:
0.317
AC:
352508
AN:
1111552
Other (OTH)
AF:
0.283
AC:
17053
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
17539
35079
52618
70158
87697
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11158
22316
33474
44632
55790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.243
AC:
36930
AN:
152230
Hom.:
5629
Cov.:
33
AF XY:
0.244
AC XY:
18168
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.0592
AC:
2462
AN:
41586
American (AMR)
AF:
0.266
AC:
4066
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.362
AC:
1256
AN:
3472
East Asian (EAS)
AF:
0.185
AC:
959
AN:
5182
South Asian (SAS)
AF:
0.265
AC:
1276
AN:
4824
European-Finnish (FIN)
AF:
0.352
AC:
3720
AN:
10574
Middle Eastern (MID)
AF:
0.320
AC:
94
AN:
294
European-Non Finnish (NFE)
AF:
0.327
AC:
22255
AN:
67980
Other (OTH)
AF:
0.256
AC:
541
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1383
2765
4148
5530
6913
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
378
756
1134
1512
1890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.299
Hom.:
11734
Bravo
AF:
0.224
Asia WGS
AF:
0.236
AC:
821
AN:
3478
EpiCase
AF:
0.332
EpiControl
AF:
0.330

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Spermatogenic failure 18;C4539798:Ciliary dyskinesia, primary, 37 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.31
CADD
Benign
4.5
DANN
Benign
0.92
PhyloP100
-0.51
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1546737; hg19: chr3-52407041; COSMIC: COSV70227362; COSMIC: COSV70227362; API